762 related articles for article (PubMed ID: 29156047)
1. Immunopathogenesis of Hepatitis B Virus.
Tseng TC; Huang LR
J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
[TBL] [Abstract][Full Text] [Related]
2. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
Wu D; Ning Q
J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
[TBL] [Abstract][Full Text] [Related]
3. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
4. TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Boni C; Vecchi A; Rossi M; Laccabue D; Giuberti T; Alfieri A; Lampertico P; Grossi G; Facchetti F; Brunetto MR; Coco B; Cavallone D; Mangia A; Santoro R; Piazzolla V; Lau A; Gaggar A; Subramanian GM; Ferrari C
Gastroenterology; 2018 May; 154(6):1764-1777.e7. PubMed ID: 29378197
[TBL] [Abstract][Full Text] [Related]
5. Update on hepatitis B virus infection.
You CR; Lee SW; Jang JW; Yoon SK
World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
[TBL] [Abstract][Full Text] [Related]
6. Effects of antiviral therapy on the cellular immune response in patients with chronic hepatitis B.
Luo G; Feng X; Huang Y; Yi T; Wang D; Guo X; Yan H; Zhang G
Mol Med Rep; 2015 Feb; 11(2):1284-91. PubMed ID: 25371014
[TBL] [Abstract][Full Text] [Related]
7. Advances in therapeutics for chronic hepatitis B.
Yang N; Bertoletti A
Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
Gao Y; Zhang TY; Yuan Q; Xia NS
Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
[TBL] [Abstract][Full Text] [Related]
11. Novel targets for hepatitis B virus therapy.
Testoni B; Durantel D; Zoulim F
Liver Int; 2017 Jan; 37 Suppl 1():33-39. PubMed ID: 28052622
[TBL] [Abstract][Full Text] [Related]
12. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.
Novotny LA; Evans JG; Su L; Guo H; Meissner EG
Viruses; 2021 Jun; 13(6):. PubMed ID: 34207487
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
14. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
[TBL] [Abstract][Full Text] [Related]
15. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
16. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
18. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments.
Laupèze B; Vassilev V; Badur S
Expert Rev Gastroenterol Hepatol; 2023; 17(11):1135-1147. PubMed ID: 37847193
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy of chronic hepatitis B.
Brunetto MR; Bonino F
Intervirology; 2014; 57(3-4):163-70. PubMed ID: 25034484
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenesis of HBV Infection.
Wu J; Han M; Li J; Yang X; Yang D
Adv Exp Med Biol; 2020; 1179():71-107. PubMed ID: 31741334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]